1. Home
  2. JCSE vs SNGX Comparison

JCSE vs SNGX Comparison

Compare JCSE & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCSE
  • SNGX
  • Stock Information
  • Founded
  • JCSE 1999
  • SNGX 1987
  • Country
  • JCSE Singapore
  • SNGX United States
  • Employees
  • JCSE N/A
  • SNGX N/A
  • Industry
  • JCSE Miscellaneous manufacturing industries
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCSE Consumer Discretionary
  • SNGX Health Care
  • Exchange
  • JCSE Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • JCSE 7.6M
  • SNGX 7.4M
  • IPO Year
  • JCSE 2022
  • SNGX 1987
  • Fundamental
  • Price
  • JCSE $1.49
  • SNGX $2.39
  • Analyst Decision
  • JCSE
  • SNGX
  • Analyst Count
  • JCSE 0
  • SNGX 0
  • Target Price
  • JCSE N/A
  • SNGX N/A
  • AVG Volume (30 Days)
  • JCSE 16.9K
  • SNGX 44.9K
  • Earning Date
  • JCSE 10-30-2024
  • SNGX 03-14-2025
  • Dividend Yield
  • JCSE 6.04%
  • SNGX N/A
  • EPS Growth
  • JCSE N/A
  • SNGX N/A
  • EPS
  • JCSE 0.12
  • SNGX N/A
  • Revenue
  • JCSE $14,723,999.00
  • SNGX $364,183.00
  • Revenue This Year
  • JCSE N/A
  • SNGX N/A
  • Revenue Next Year
  • JCSE N/A
  • SNGX $76.64
  • P/E Ratio
  • JCSE $12.07
  • SNGX N/A
  • Revenue Growth
  • JCSE N/A
  • SNGX N/A
  • 52 Week Low
  • JCSE $0.63
  • SNGX $1.83
  • 52 Week High
  • JCSE $2.39
  • SNGX $14.88
  • Technical
  • Relative Strength Index (RSI)
  • JCSE 46.75
  • SNGX 43.83
  • Support Level
  • JCSE $1.43
  • SNGX $2.25
  • Resistance Level
  • JCSE $1.71
  • SNGX $2.60
  • Average True Range (ATR)
  • JCSE 0.08
  • SNGX 0.15
  • MACD
  • JCSE -0.02
  • SNGX 0.03
  • Stochastic Oscillator
  • JCSE 24.14
  • SNGX 52.27

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: